A Survey on Migraine Prevalence in Patients with Inflammatory Bowel Disease - A Single Centre Experience

Somaye Chehel Cheraghi, Naser Ebrahimi Daryani, Mojdeh Ghabaee

Abstract


BACKGROUND

It is hypothesized that migraine may be related to inflammatory bowel disease (IBD), therefore in this cross-sectional study we evaluated the prevalence of migraine in patients with IBD.

METHODS

In this cross-sectional study 80 patients with IBD and 80 patients without IBD referring to gastroenterology office (Dr Daryani’s office) from May to January 2014 were evaluated regarding the prevalence of migraine, severity of migraine based on Headache Impact Test (HIT-6), and habits related to headache.

RESULTS

160 participants with the mean age of 35 years were evaluated. The prevalence of migraine in the case group was significantly higher than the control (21.3% vs. 8.8%, p=0.027). Moreover duration of each attack (hours) in IBD group was significantly higher than the control group (p<0.001) while the duration of migraine involvement (months) and number of attacks was higher in the control group (p=0.019 and 0.048, respectively). Headache other than migraine in the control group was significantly higher than the IBD group (p<0.001). Disability in the case group was more than the control group but the difference was not significant. The correlation between the severity of disability related to migraine (based on HIT-6) and severity of IBD (based on Mayo score & Crohn’s disease activity index (CDAI)) was not significant (r=0.16, p=0.58). Moreover the correlation between the duration of IBD and migraine prevalence was not significant (r=-0.14, p=0.19).

CONCLUSION

We found that the prevalence of migraine in patients with IBD is significantly more than normal population. More studies are needed to highlight the correlation between migraine and IBD.


Keywords


Migraine, Inflammatory Bowel Disease, Headache, HIT-6, CDAI

Full Text:

PDF


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.